How Is The Market Feeling About Theriva Biologics?
Portfolio Pulse from Benzinga Insights
Theriva Biologics (NYSE:TOVX) has seen a 58.82% increase in its short percent of float, now at 0.27% of available shares. This rise in short interest suggests a bearish sentiment among investors, although it remains below the peer group average of 2.48%.
September 09, 2024 | 5:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Theriva Biologics has experienced a significant increase in short interest, indicating a bearish sentiment among investors. However, its short interest remains below the peer group average, suggesting it may not be as heavily shorted as its peers.
The increase in short interest by 58.82% suggests that investors are becoming more bearish on Theriva Biologics. However, since the short interest is still below the peer average, the bearish sentiment might not be as strong compared to its peers. This could lead to short-term downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100